Replay of our webinar about BIOMIMESYS Oncology for modelling cancer in 3D

Have you missed our last webinar with Molecular Devices about 3D oncology models?

In April, our project leader Elodie was talking about how to establish and image physiologically relevant 3D cancer in vitro models, using BIOMIMESYS Oncology as a surrogate for the tumoral extracellular matrix. Our product BIOMIMESYS® Oncology matrix allows cancer cells to be cultured in a tumor-like environment, with the possibility to tune both the composition and the stiffness of the matrix. 

We are glad to share with you the link for watching this webinar when you have time!

https://www.labroots.com/ms/webinar/physiologically-relevant-3d-ecm-vitro-oncology-research-intelligent-high-content-imaging-3d-models

The main learnings objectives of this webinar are:

• Utilizing a relevant 3D cell culture platform (BIOMIMESYS®) for oncology research
• Optimizing the setup of a high-content screening platform for 3D in vitro models
• Improving sensitivity, speed, and assay quality for 3D and complex biological assays using a high-content imaging laser-based system

Special thanks to our partners from Molecular Devices (Sarah Piper, Guillaume Frugier, Stephane Cardon…) and Michelle Ashton from Labroots for organising this webinar! Always a pleasure to work with you. Looking forward to collaborating again 🙂